Metabolic Pathway Peptides

Retatrutide 5mg

$55

This product is intended for research purposes only. Not intended for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you acknowledge that you are a qualified researcher and understand the nature of this product.

Retatrutide is a 39-amino acid synthetic peptide bearing a C20 fatty diacid modification and acting as an agonist at the GLP-1, GIP, and glucagon receptors; supplied in a 5 mg vial.

RetatrutideMetabolic Pathway Peptides

Overview

Retatrutide is a 39-residue synthetic peptide derived from the glucagon superfamily scaffold, carrying a C20 fatty diacid moiety attached through a linker at a single lysine residue. This acylation confers non-covalent affinity for serum albumin. The peptide is supplied as a lyophilized white powder.

In receptor binding and cell-based assays the molecule acts as an agonist at the GLP-1, GIP, and glucagon receptors, all class B G-protein-coupled receptors signaling through cyclic AMP. This vial supplies 5 mg of peptide; the compound is identical across vial sizes.

Mechanism of Action

Acts as an agonist at the GLP-1, GIP, and glucagon receptors, class B G-protein-coupled receptors signaling through cyclic AMP; the C20 fatty diacid moiety confers non-covalent serum albumin affinity.

Certificates of Analysis1

Independent third-party lab reports for this peptide. Each CoA can be verified against its accession number at the testing lab.

1 independent test by Freedom Diagnostics Testing

TestResult
Purity (HPLC)99.952%
Identity (MS)Pass
Endotoxins (LAL)Pass

Lab: Freedom Diagnostics Testing

Accession: 2602120077 / 2602120078

Reports are verifiable against the issuing lab using the accession or batch identifier above.

Other compounds in the metabolic pathway peptides category.